Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Host First-Quarter 2020 Earnings Conference Call
NORTH CHICAGO, Ill. , April 2, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its first-quarter 2020 financial results on Friday, May 1, 2020 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Feb. 20, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.  The cash dividend is payable May 15, 2020 to stockholders of record at the close of business on April 15, 2020 .
Toggle Summary AbbVie to Present at the Cowen 40th Annual Health Care Conference
NORTH CHICAGO, Ill. , Feb. 19, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40 th Annual Health Care Conference on Wednesday, March 4 , 2020.  Michael Severino , M.D., vice chairman and president and Robert A.
Toggle Summary AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , Feb. 11, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the SVB Leerink 9 th Annual Global Healthcare Conference on Tuesday, February 25.  Michael Severino , M.D., vice chairman and president and Robert A.
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
- Reports Full-Year Diluted EPS of $5.28 on a GAAP Basis, an Increase of 44.3 Percent; Adjusted Diluted EPS of $8.94, an Increase of 13.0 Percent - Full-Year Net Revenues Were $33.266 Billion, an Increase of 1.6 Percent on a GAAP Basis; Adjusted Net Revenues Grew 2.7 Percent Operationally;
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2019 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 13, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its fourth-quarter and full-year 2019 financial results on Friday, February 7, 2020 before the market opens. AbbVie will host a live webcast of the earnings
Toggle Summary AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Jan. 3, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 . Richard A. Gonzalez , chairman and chief executive officer, will present
Toggle Summary AbbVie Reports Third-Quarter 2019 Financial Results
- Reports Third-Quarter Diluted EPS of $1.26 on a GAAP Basis; Adjusted Diluted EPS of $2.33 - Third-Quarter Net Revenues Were $8.479 Billion, an Increase of 3.0 Percent on a GAAP Basis, or 3.5 Percent Operationally - Third-Quarter U.S. HUMIRA Net Revenues Were $3.887 Billion, an Increase of 9.6
Toggle Summary AbbVie to Present at the Wolfe Research Inaugural Healthcare Conference
NORTH CHICAGO, Ill. , Oct. 24, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Wolfe Research Inaugural Healthcare Conference on Wednesday, November 6.  Richard A. Gonzalez , chairman and chief executive officer, will present at
Toggle Summary AbbVie to Host Third-Quarter 2019 Earnings Conference Call
  NORTH CHICAGO, Ill. , Oct. 8, 2019 /PRNewswire/ --   AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its third-quarter 2019 financial results on Friday, November 1 before the market opens. AbbVie will host a live webcast of the earnings conference call at 8